Correcting hyperlipoproteinaemia is crucial to prevent or regress atheroma. Lifelong treatment, including diet and medication, is essential for managing lipid levels and preventing complications.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Hyperlipoproteinaemia contributes to atheroma formation and cardiovascular disease.
Effective management requires a multi-faceted approach, often involving both diet and medication.
Long-term adherence to treatment is critical for sustained lipid level control.
Purpose:
To outline the necessity of correcting hyperlipoproteinaemia.
To emphasize the role of dietetic and medicinal treatments.
To highlight the importance of continuous management and monitoring.
Summary:
Hyperlipoproteinaemia necessitates correction to prevent or regress atheroma.
Initial treatment involves diet, supplemented by medication if needed.
Treatment must be indefinite; normal lipid levels indicate effectiveness, not discontinuation.
Non-adherence to diet is a common cause of treatment resistance.
Monitoring for iatrogenic complications is essential.
Commonly prescribed drugs include resins, fibrates, probucol, and HMG coareductase inhibitors for hypercholesterolaemia, and fibrates and nicotinic acid for mixed hyperlipidaemia.
Impact:
Improved prevention and regression of atheroma.
Reduced risk of cardiovascular events associated with hyperlipoproteinaemia.
Enhanced understanding of long-term management strategies and potential complications.